INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (140097, 14605, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'NCBI', 1768172794, 1768172794, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (140098, 14616, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'NCBI', 1768172796, 1768172796, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (140099, 14652, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, X'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', NULL, NULL, NULL, NULL, NULL, 'NCBI', 1768172799, 1768172799, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (140100, 14659, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'NCBI', 1768172802, 1768172802, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (140101, 14659, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'NCBI', 1768172804, 1768172804, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (140102, 14659, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'NCBI', 1768172807, 1768172807, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (140103, 14659, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'NCBI', 1768172809, 1768172809, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (140104, 14659, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, X'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', NULL, NULL, NULL, NULL, NULL, 'NCBI', 1768172812, 1768172812, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (140105, 14752, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'NCBI', 1768172814, 1768172814, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (140106, 14764, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, X'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', NULL, NULL, NULL, NULL, NULL, 'NCBI', 1768172817, 1768172817, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (140107, 14774, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, X'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', X'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', X'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', NULL, X'789c6d93cd6edc300c845f8597023d3841d0a4bd1b3df516609353900357a26da1b224485476fdf61dc9c976fb73320453c3e137d4d3222467364aba48e624559d2117ac9c294e64ab7251c9ce0ab942212a9dc4fb1b2b930b6207e26029b13a095a48f9a70b3339a5b2c4ea2d1d8556c6553e7196a68726c4a544e358c512db37c9050ea6498c965b7af9f2f04a8f1f7aef2a5952cc8a561b1db3c00f49f09c6759514531930afce620a540bc1b6cdf565fe45cd95369fe2f4dfed6874b136b28e26129866e72da9170e70287ff11c2681b25f87770c413289175c5c4a02e54b480d29f0431de3dc67b79b87ba5efde05070ae1e2628dc12986b9d09c70286e46056438107b2f79463a6060babcc66bf901b1195fed1e8159f01da82011ca5c9681bc4b65c09d3057d4421c3362b0860ba5ff62291ad347a4d77bd0227701eed6c6c6655a84bd2ea645acc22bb9a9b3dfe36eecb635695c0ba58c6350b4cab12836800c07036e4db2e6e823c603656044cc721d50ae3d9caa38a035b611b4b044cddcbeb9dbbe8bf0186d53f1db2d8d08090dc10a9785b37792077a3c8c6d99e59c10237e348c62da66091d2193528e67b7c29fdfe8ebdd2724e17d3cb556f7adf85bcb4a979e8be29aae7da827d8e8def02a28c8898e10045ab91a4330f6d1bbb2ec6de58d7d6d1c52d4e613b3ef446eb2f8fe42ccc261060914c3766f42e38a215147cfbf918def8faaadc561e74d3ffa2bfe3c3e8f37875f90ea6d84', X'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', X'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', NULL, 'NCBI', 1768172819, 1768172819, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (140108, 14829, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'NCBI', 1768172821, 1768172821, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (140109, 14829, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'NCBI', 1768172824, 1768172824, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (140110, 14837, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'NCBI', 1768172826, 1768172826, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (140111, 14881, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'NCBI', 1768172829, 1768172829, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (140112, 14881, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'NCBI', 1768172831, 1768172831, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (140113, 14882, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, X'789c5590cb51c4400c445351005be4c0a73873e32cc6b2ad622cb924cd2ebe9103096c2c84422468bc7cafa39e7edd7da32ff088262c9303ca000f46055bb08ac3b5c34af67ebebfbb06a3a955bcbc771daeabe911eb01622650a91bf84a85472e5054c29065e0b2ff80510d96b6b26961017678163d09cc5bda3b8973f091634b08960b2274f75de8c7232d383cbd97558524fc0a7aaef54f5e9652db40b06aa480b102d64a3665a41fe703d0467b83aa25156cc6815fa744aa51703f18fb33e808b7553d8c076e0b0c3c663faef4f1fa06e89e753068783f0f8c6633e101162ea64f9dadc7449b9e623e40934be3a515f5bcd138528924b204d977e913c79ce1eb46316f958460aa5bd1dcb8e7ed7bfc36eb938e4da60e32784a0bb2ffd48b5d739cb26f7492e191445b8e8869961f2097a74c810e1ebd49aa764e5f766a3c506521df613789c86628579fbc4ed5a1', X'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', X'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', NULL, X'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', X'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', X'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', NULL, 'NCBI', 1768172833, 1768172833, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (140114, 14883, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, X'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', X'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', X'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', NULL, X'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', X'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', X'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', NULL, 'NCBI', 1768172835, 1768172835, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (140115, 14884, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, X'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', NULL, NULL, NULL, NULL, NULL, 'NCBI', 1768172838, 1768172838, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (140116, 14891, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'NCBI', 1768172841, 1768172841, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (140117, 14947, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, X'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', X'789c4d534b8ed43010bd4a69d64d034282f5088406891d880d6251b12b7169fc09fea495dbcc59e6643c3bd3f46ca2d8aa57f53ee5fb8dd5f3e485bea4c28bd0d79443218e967ed42c71a9aed0679e67d128a485d25459e340cc3905da386b6a854a6ad948399146e39bd5b8904980094dc211f7860da7ebe13179a6d82a7eab3079e1ad6377c91353e02aa741a13aa1a571e6c840e6bc9fe95b24b656aba6d87bde889914428a7ea7393540b98b7829dd5010c1d0f2a14ca2e465279b353e425106369616c4f6b2355dace47e5bbbca8a7e399ce9f7a73f743f9594d73e1a1c7730a2e275711543ad78ded1e0e22402f888ef45ab0338d9f3f3d34f08295543f31cebf3930135a0d9068d5aaa642037e5a17765d88e2bf69453eb4e5c9c1ad725327a803f674b41aa4bd77159b876c3798d3033cdb46681892d6bddbba4289729e538a4aea9d437b6f5f66b8b0645424ed8b2715260efafa1173cbbccf2fc0436c4ff9704cd3ebea3b0bcfd40e1fbcd7ea33523b4aec123c635a74dc70a40a7fc6dbab18726b2c78a81e0fbd1e4558b33dd7b888edcd3f2fbab68af5e75ef27f894c554f6bd4411da3c83a9d85397a6d1618e3dd343bac826f9f492eb915875b073713754bfbca28e132caefbaaa6b71f58b5231a1e9e74de414b2b20a37d59b8125c53d98652ba73d885f31d216b948cec0ad896e66bf72d348438734ffb10b31e3b7c9bd817a6176aecd0e3054cfbcaa58cc5983523ba7144fa3c25af250cdfdc10067039c60ecff0a6f08052277f0cfd0766916f71', X'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', NULL, X'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', X'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', X'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', NULL, 'NCBI', 1768172843, 1768172843, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (140118, 14962, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'NCBI', 1768172845, 1768172845, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (140119, 14962, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'NCBI', 1768172847, 1768172847, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (140120, 14962, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'NCBI', 1768172850, 1768172850, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (140121, 14968, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'NCBI', 1768172852, 1768172852, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (140122, 14986, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, X'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', NULL, NULL, NULL, NULL, NULL, 'NCBI', 1768172855, 1768172855, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (140123, 14986, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, X'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', X'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', X'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', NULL, X'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', X'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', X'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', NULL, 'NCBI', 1768172857, 1768172857, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (140124, 14987, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'NCBI', 1768172859, 1768172859, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (140125, 15007, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, X'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', X'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', X'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', NULL, X'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', X'789c85534b6e134110bd4a2d13c9b684040b60158442d80424b28bb22877d7783aeee91af5c7f6709a5c800bb0f4013813af7b6239c00269a4f6b4abdea75ecd5d2f2407369906313d079706d2eef8f46679f5edeaf8e41295b00dba0f2bbad1bdec242e28a3a79f46c599508027f79cc901436df19c25b51a173acfc3c059e34451d2a8210959896e2796baa8432b3393f1aa87692381f13f074bde8d2f6e46cefd9ea7b440af89c2c9854deb4c5378d6a01d8d5153e68d47bf0b698691b2d51c9d0449abe3d3171447826e09d9b13f3b8687607cb1557296d849946084f62ef78d07d0b698ec3454a23f6c9929ebd6019f768e611275277518aadbb93cd59e508c178ed4e152e3f107fdfaf9812e6eaf97382f9b56177ab776278e5c068d146057abbdb98d2eee6eaf2f1764c47b8c1968253455cdff508c26b8f2d330f60a5d82810d0c84b1e74d7da934817389a8da3aef318c0a5547d3e2a69e31379f94d62201834ab9a569a9de2330118a6c9d417f32bc93b0014445e580074a0ecee25cd1fddb07ba7ff5fa81bef61ca1a18d283b93e86a9d348e55f43b9a490d9ad78255035aaa640a7d7e9a390d8fa978c11d5e32afbde439165cd4534ba64ed5c2c24719a546bf218cb0cebfd33854fde05a9c1cce64c80969a46a2c93755d0b3c53727573d9eb73809f3e538e98fc8aae4187af6418bdcceb3fa359f13c895d3ec39dd4a67f69c2b4c7eec979e91fe5b18482dfda5ea31844fefe05f678b3b4cd51557626f81faec3ceff85ba2088ea18bbc1df11c36f88f976e4', X'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', NULL, 'NCBI', 1768172861, 1768172861, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (140126, 15023, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, X'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', X'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', X'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', NULL, X'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', X'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', X'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', NULL, 'NCBI', 1768172864, 1768172864, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (140127, 15024, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, X'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', X'789cb593c16edb300c865f85c704708c244dba613b651806ecd053f702acc4c642652993a864791b3f8b9f6ca49c6458bb1e77922d51e4cf8fbf7647741e9f3cc1d798714ff02da63e03060b8f9c28ecb9cbf0a32388093d3ccb61f1c82e0688cfb05dec1e77e3e024fe96063358f27826bb48e4093381c1432e9e32cc36cb25f4fb7903f48b29d87fc6acb71ad3c0dd876d5d55caf67a4f7f5ea767adcb72f3638daa31abf574a31d878bc8774569f8350526821019b8a384072aec0c7a7f06fa59dc113d0586999eefbe2c1232d9f967e828186ac078179c711832e42e166fc1c4909da5a4c9fe02577b88b96e4e085bf82edbd63a3d6fc03108d24426f67da534698a600a4ba58e4e8d8c034c2ab9bbf4f716e821455b0ce72b016938c093d27aa150a7297dc9b0f04a4253e285049c1c77baa16b2c2c52a36dab0f4416bf71c2b5c66b2748490ad4a34c1ef6f3da39422e8743cc8e633ac36cb59c06053b5b3c5f4df8e0bc5d705cf451000a68956ad81d098a37baa39f267a01963f8dc345d70d9715096765acb9c4a7af66ff87c86481eae0c93ce37007ec7ab145cdd1c0a973a603ec6309e20f99c1badd8cc3beceee1e4e442fb985077441f0a33841cb25ea5dce9737f29f04ab5f045856e4abf65e2509e3e97ddde2e61a380e6bd13d0e1bb0eee86a35315f6e7f03292f6df6', X'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', NULL, X'789c45914152c3300c45afa21d3013ba631896a5dc80ee3a5d38b6d268ea48c1b207729b9c2527437149d94996f4f4f5fd5110b22cf3cbf3fe73ffa016ff90a73c5900b947b852609cb4a9498f2ee6debb6433e806d05e4a0c30085396545b469709391b2921bb085d619f49185aecc4e61c070825115f6a7b5104e92c248590ca65b7cc0719c68819a18d2201bc14cef078783f3c2df3df4217550c08be477fc50046865618617029c9376819c784aab6b701d4113db91827205e668901d326537770ac77adb9ff179bf0ab9011b6d356b9a13a753b528cdd4684447a5df5df018e6249d8983289a8b93ede8a99ccc4ad8f584bd799d1c87e6aaa2962e0044a17d69aeb348c5906bde365fb9a1d9cdece707a3dff02f8a2a5ba', X'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', X'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', NULL, 'NCBI', 1768172866, 1768172866, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (140128, 15037, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'NCBI', 1768172868, 1768172868, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (140129, 15037, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, X'789c7d53bd8e1331107e9569e8f62210a2a13ba828d0215d41812826b6f77690d7b39ab1932c4f73cf724fc6e75d7202e974528ad8197ff3fde5935ee83b5b91f2e0f4594b3596122570152d4ea3dad3e3879bdbfb5b9212728b89a67549e6a9b85439495da92a6d13033967096be69a7c2035e2598afe737978610367d767ec0597a954a7b3d4893c9d9225b2543877b829f5df03c9bcb0d88cc103ddd529198597885373a8bad267203593c206c6c6a1921ebd5a0b7d9eb8448c2710c167e44ea15ffdcf275dc42b20e981f11244b023368d1bbf96036c39d08f776f7f5e1ddd30be590adc76565f13dce8aea41b906d2145e2d06adf5b3527e31212f95aa2e99c3eeeb63e3d72c40bacb64d1b09b8b96b10581a77665c5ec119e83c499868e6958e89a28ca384966b0fae1fe071a91d8c468c77ac74618839eeeb74dcb5e1744a703a2377e8fc526962270da19981079ce36531bdc80ca8bcd2fb37fd29e2d9d3d19c3115329404d8e5b5c595165d5afe9b988ed7a860abb73c72f7ea37bc3ad0fd3a2f5567471716b5baaddb1bc3c7a8700788e844192818cf0bac1fd0168e1c26c89f81238e2f8ba101b5a19ca0f4ab95b035587036f669a0635605ab286c86e7c3969fc3c22a7342a77a1fd1e14d833038fba42d479ab54805ebe7ba84acde3de82d3c6bffb7f436c08e5e5aa88500bf4a423839ed5ddd0387b7e32b71f6fcbdf992027c18486abf40c774067804729d18d95ae2dab7ed05d980ff00dc2075fd', X'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', X'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', NULL, X'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', X'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', X'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', NULL, 'NCBI', 1768172870, 1768172870, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (140130, 15040, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, X'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', X'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', X'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', NULL, X'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', X'789c85534b6e134110bd4a2d13c9b684040b60158442d80424b28bb22877d7783aeee91af5c7f6709a5c800bb0f4013813af7b6239c00269a4f6b4abdea75ecd5d2f2407369906313d079706d2eef8f46679f5edeaf8e41295b00dba0f2bbad1bdec242e28a3a79f46c599508027f79cc901436df19c25b51a173acfc3c059e34451d2a8210959896e2796baa8432b3393f1aa87692381f13f074bde8d2f6e46cefd9ea7b440af89c2c9854deb4c5378d6a01d8d5153e68d47bf0b698691b2d51c9d0449abe3d3171447826e09d9b13f3b8687607cb1557296d849946084f62ef78d07d0b698ec3454a23f6c9929ebd6019f768e611275277518aadbb93cd59e508c178ed4e152e3f107fdfaf9812e6eaf97382f9b56177ab776278e5c068d146057abbdb98d2eee6eaf2f1764c47b8c1968253455cdff508c26b8f2d330f60a5d82810d0c84b1e74d7da934817389a8da3aef318c0a5547d3e2a69e31379f94d62201834ab9a569a9de2330118a6c9d417f32bc93b0014445e580074a0ecee25cd1fddb07ba7ff5fa81bef61ca1a18d283b93e86a9d348e55f43b9a490d9ad78255035aaa640a7d7e9a390d8fa978c11d5e32afbde439165cd4534ba64ed5c2c24719a546bf218cb0cebfd33854fde05a9c1cce64c80969a46a2c93755d0b3c53727573d9eb73809f3e538e98fc8aae4187af6418bdcceb3fa359f13c895d3ec39dd4a67f69c2b4c7eec979e91fe5b18482dfda5ea31844fefe05f678b3b4cd51557626f81faec3ceff85ba2088ea18bbc1df11c36f88f976e4', X'789c5552bb8e1b310cfc157ec0c64d102429af0a5204297c5de08296b85e229228e8e1dcded7f85bfc6519ade38bafd885209133c319eef5942a71f2b45f636e162bd94c3fcf52bc55a14f1f9ef64f13de89a326ab1cd4ad819b4ce47019843d35a3fad0fbbf062f2feab4ad3b7a5e845ce05ad5512b8a2e54460dfead8634b9d0bd544adcabf044678bda349da64d1e4e495baf3bda0bd4c9238fa60d859b5ada7469f2dd0915a9590b372b2b71f8cdc1aa563aae549bc68e56a0535bde173a494d4a9d68b610ec8ff8d110a5f1d14048ecd46f30be8f01b7f69e9cf51c061ac682140fe8b3505eace22b4325a4edae97bdc5c196ad34003fda6677cbfff970bd2c6bc69c51618578893caa061b270ee4164e49c2cd9b1e9c941b05fdfaf8f9403f5073928849dea58914601cb427435fc320306fb672bd6c39bf69d83d02b435c3da104642670b6724d48b26be7baaaf37df2164229d2909d4e2b84834af1c569835647d39e0f7f540dfb8b662884c90c218c58bb3d4c67edd80a0afe02a821d40c3e35c1039a4ccbdc080427cac56f26ddeefd80ab02052c9f56e1ecda1abbf5e863912c48130ac6d733ec846d29662fdb48cd5290c70eb75985b38af6392eb25f2909838618f463ca08ba0293224cf487ca3ff0b75b13940', NULL, 'NCBI', 1768172873, 1768172873, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (140131, 15041, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'NCBI', 1768172875, 1768172875, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (140132, 15052, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, X'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', X'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', X'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', NULL, X'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', X'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', X'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', NULL, 'NCBI', 1768172877, 1768172877, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (140133, 15070, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, X'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', X'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', X'789c6553416e1b310cfc0a2f461dc030e23869d26381a0684f055adf0c1fb812d7cb66256d45c98efb83fea32feb4b4a6eecb4762f8b5d911cce8c66dffb1d652178cc750b5f085de11405bea6403060618a45a0e013c72df85a500a65f604010f40cf837e50740442cf157bf007696b1c3166b0efd875e0306a73e496a4000a7018521967a6d7f3e5044a82c5cde46a069e5c2614f2d073c33ec1b40e56bd9ddf593965f0dcb6ec6a5f74f537d417e5a7b48e7df7f387c9d51cd637d71b582f6fed71b7815547f24a0f8f62a96dc9a92e13a11284959a2719b8902e1197a202d70bc973f85073e9288794690672e650873b824c43ca4505bc1a63104a54616be688f9a03d2adefc317b7a3d97ffd6ac976f47de6695de07a4f6cc791d6d2917ee597de8d4d1980a34448aa8e5fe0052aa67f233686a812153cfe1b45bd43cbd82e8d9a1922a1d1608dc7b2df97abc7a8e6a5750b8013306a59b5f8c6ac8c044d91fa91f53a19640a01151e78dfefd063e47ba701b7a12019742485149a248728ce6d69e4b77a69005b68748daab478c30fdfdf3d7c232803aafdc47fb5ca7f49c4dfc508ce630f2f0b4a33e0dc148aa6d8d05aa4061914a262c60fff7d28ceac3312bab4e979efc69730a231cc74ea338ae53b4a2094ec631457a6352a2e9b3a2a6eff1e30a30fa714c6a23f4bd1a098e2fa1b6e556b25c0c9a210de33ff317e086a79f396dc9fc5cbcdbc0a778fa394e0573e929a6fdb8dd611d779c9ad0b91ac6ffe305dd8cf803504c6d82', NULL, X'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', X'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', X'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', NULL, 'NCBI', 1768172879, 1768172879, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (140134, 15101, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'NCBI', 1768172881, 1768172881, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (140135, 15153, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, X'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', NULL, NULL, NULL, NULL, NULL, 'NCBI', 1768172884, 1768172884, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (140136, 15167, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, X'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', X'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', X'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', NULL, X'789c65504b4e03310cbd8a0f005df40a5d7302d44548dc89c1638f6ca7309c1e07844688451459eff97d7cc1db30fda015a1b495843cac04a94091064d9d6401c18aee142526eb7578ac280124101d6141a312461536dd061fdb248deed4466187778a9eb81a184a61b80da993788227150ab5e9f3170272a8362a157e80ad58504d75e37d1a57a39c0bcf8939e1a08ce42951314d53acd3d2d16605f4ef38ca2de75fe6092e9c75535d1cbcebe006195461fdc9039b6974d3f565d69cf7c9bfc4a391bf1d765397e99eba289ffb9a4ec9fad7bbe35ca8d0763f7a3f9faff9ced72f0ba09156', X'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', X'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', NULL, 'NCBI', 1768172886, 1768172886, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (140137, 15168, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'NCBI', 1768172889, 1768172889, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (140138, 15168, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'NCBI', 1768172891, 1768172891, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (140139, 15171, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, X'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', NULL, NULL, NULL, NULL, NULL, 'NCBI', 1768172893, 1768172893, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (140140, 15173, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, X'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', NULL, NULL, NULL, NULL, NULL, 'NCBI', 1768172896, 1768172896, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (140141, 15188, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, X'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', X'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', X'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', NULL, X'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', X'789c6d53cbae13310cfd15ef00a9ad544082ed70592236b04377e1493c1deb66e251e2b41dbe866fe1cb70d2767a85ba9947727c7c7c6c3fe13010477a93614e3c615a60223762e43c810c804e5922703c4a385206d60c6421cede768e9ea2648b87448e66956490083a12f40939eee08bb11fa0171d6140dd02460f27544adb2ca1f481c0c9344ba4a81b7057354098392ce092e46c591b5f10f1dbc60a3da6c4941a1946c58344fe6d380c013e3e1005b9f4bacc8678dbed37d0bdc7fae8378da0fbf06e073f2dc38de95279cd69c03b079b4598945d09984c5ca26cba33d71a06bb77772b4ff842430991f2ead60e7eed3f3ddbe3f333740f5cc344104521f0c44a1e549a82a7ef3fa02f5aaffffe992da5f9641749ca6194a21767c42f3bf8ca46a6ff15b18aeff6b52f0e9367743095ec82b9617c25686bd96c82948f64dfa249667677e5dff8854e9c69f3c8da5709b3f264e6e8b5638982f591aa0e67876e948093c5666bb4444d6c85d5e1b8969a97ac3459de1b8dd830aeb336dc87a3366d28c962d28aad3cb7eaae152c0de8ccabebff0eba8b6147ccad8910e848e1d5d895e8291dc4f4d7a10c74362e1bd5cb12e42ab4099770a7501bdd8dc15c28be8af08fdab0a21fed8bb1ce4926d1264c3cd772ea6e99fad551a0e86d872830067014428bbb391cd9dc742067f626e634b21b57870c8367caff00907872a7', X'789c6553cb6e143110fc95fe8065d94459e51c11210e200e89c40171e8d83d33adf831b23db319be866fe1cba8f6262488cb3c3c76557555cd9d8ea912274f775b9c5b8e95f2405f57293e57a10f3c0ca249c8e554176cd09c482b8d92a470081b1519b978f1c4952a0fb2a71befb5e98a332f873551ccb5515d1e6ae3e4a492cfb8a4dc28095eab366e421f6f6f88e7b9e49583e1859c46bbbf252f125921f9a46d02ae5152905502e89bce4b0090a7878dda2458e1b634d3446d9bd501b68f85115fc561fc921738707da096e9e270a038d22c857cd1f4b8a76f930631bcd277a70c112ec728c9e6f6acb0015ee4938d46432e7fc1779dae5bbacc067ed5c1dfc32d6079910880b36bdf8f573fe81e9ae5895da3cfb7c743879a96c81877e5a2720e2a701905945e6628003812495e57f50be6ab92aad9af6d33c217257bfa944fb0a9ecba3102af6277aa1361aa076927914417c7c3ef5f46737996fa38eed102785664cea5d5cee52cad36717b9eaf6775b2dbf1fa7c88265eed4c5d82b120a9811b072893dae3c84feafe0b6347a7ee72452b75004d6ac41eaab14db0c581bf2e6e32a6c66eda1cbaa7bc839d65dada14fb33180b38910fe2476776ddb62afa7381208abc51766e811598fbd509b8f5202f5db8d85f1226bf7fe3558f9129e820efda54044b4951d0ff1a55388de841c91165ea95ba32ac2f9c781453f5cf2f6614cdd0fa178b3c6a30c7462346f3692ee02fd6324d6b0eab9809b3a571fecbcadb74e1b4e3e7cec56c5edabad01f69456592', NULL, 'NCBI', 1768172899, 1768172899, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (140142, 15261, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, X'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', X'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', X'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', NULL, X'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', X'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', X'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', NULL, 'NCBI', 1768172901, 1768172901, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (140143, 15265, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, X'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', X'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', X'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', NULL, X'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', X'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', X'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', NULL, 'NCBI', 1768172903, 1768172903, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (140144, 15384, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'NCBI', 1768172905, 1768172905, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (140145, 15394, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'NCBI', 1768172907, 1768172907, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (140146, 15408, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, X'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', X'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', X'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', NULL, X'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', X'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', X'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', NULL, 'NCBI', 1768172910, 1768172910, NULL, NULL, NULL, NULL, NULL, NULL, NULL);